DID YOU KNOW?
- Researchers analyzed data from 11,707 dengue patients and 1,248,326 COVID patients in Singapore between July 2021 and October 2022 to study new health issues affecting the heart, neurological, and immune systems that surfaced 31 to 300 days after infection
- PfizerForAll is an intuitive digital platform created to streamline access to healthcare and facilitate health and wellness management for individuals throughout the U.S.
- India's bioeconomy has grown significantly, increasing from $10 billion in 2014 to over $130 billion in 2024, and is projected to reach $300 billion by 2030.
- The packaging machinery market has a turnover exceeding €9 billion.
- India has the largest number of US FDA-approved manufacturing sites outside the United States, including facilities for both finished dosage forms and active pharmaceutical ingredients. In the past five years, India has captured over 30% of the US FDA market.
- Centre bans 156 combination drugs administered as painkillers, antibiotics; more under review
- In Europe, Indian companies have obtained 2,371 Certificates of Suitability (CEPs) and have registered 348 sites under the European Union's Good Manufacturing Practices.
- The pharmaceutical market in China is projected to reach a revenue of USD 117.50 billion in 2024. The industry is anticipated to grow at a compound annual growth rate (CAGR) of 5.82% from 2024 to 2029, leading to a market volume of USD 155.90 billion by 2029.
- The European pharmaceutical market was valued at USD 282.75 billion in 2020 and is projected to grow at a compound annual growth rate (CAGR) of 5.4% from 2021 to 2028.
- The Integrated Vaccine Complex project, deemed a national priority and developed by the public sector in Chengalpattu, has yet to become operational over 12 years after its approval, despite an investment exceeding Rs 800 crore.
- Approximately two billion people worldwide lack access to essential medicines for life-threatening diseases such as cancer,AIDS, and autoimmune conditions like Type 1 diabetes.
- India generates approximately 405,702 kilograms of biomedical waste daily, but only 291,983 kilograms are properly disposed of. This means nearly 28 percent of the waste remains untreated and eventually ends up in dumps or water bodies.
- Indian pharmaceutical industry expected to reach $55 billion by 2030.
- The history of research and development in pharmaceuticals dates back to the origins of medicine itself. The evolution has been transformative, from the ancient use of herbs to today's advanced drug development techniques.
Articles
By Rameshwar Verma
An Interview with
President Maurizio Marchesini
Embracing Digital Innovations and Sustainable Practices Amidst Regulatory Pressures
An Interview with
Avinash Kumar Talwar
